76 results
8-K
EX-10.1
FBRX
Forte Biosciences Inc
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
the best available personnel for positions of substantial responsibility,
to provide additional incentive to Employees, Directors and Consultants … applicable under Section 409A. In no event will the Company or any of its Parent or Subsidiaries have any responsibility, liability, or obligation
8-K
t4peq85ke zhig5gur
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
DFAN14A
cckbp9bl3byb
14 Sep 23
Additional proxy materials by non-management
4:00pm
424B3
foco5v9r
8 Sep 23
Prospectus supplement
4:36pm
DFAN14A
kcgcn3 ff8ntvjuggju
6 Sep 23
Additional proxy materials by non-management
4:31pm
DEFC14A
b5muy2a2d46xug32ld
24 Aug 23
Proxy in contested solicitation
6:15am
PREC14A
fwwkngsztxi5uz7
2 Aug 23
Preliminary proxy with contested solicitation
5:28pm
8-K
2t0hgjq35deh
14 Nov 22
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
4:05pm
424B5
kwxjcij
12 Aug 22
Prospectus supplement for primary offering
4:46pm
8-K
EX-4.1
mozjuu4 qdu
12 Jul 22
Entry into a Material Definitive Agreement
9:12am
8-K
EX-10.1
ft5h7 t45vo7kgqe8v
31 Mar 22
Entry into a Material Definitive Agreement
8:57pm